Blog

Study Shows Inactive B2M Gene is Recurrent in Lung Cancer and May Condition Response to Immunotherapy – Scicasts (press release) (blog)

Study Shows Inactive B2M Gene is Recurrent in Lung Cancer and May Condition Response to Immunotherapy
Scicasts (press release) (blog)
The new immunotherapy treatments aim to block the activity of certain proteins that inhibit the immune system. In lung cancer, this therapeutic option has yielded hopeful results in about twenty percent of patients. However, the treatment can only be

2017-01-19 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.